Wellnex Life Limited (ASX:WNX) Places Shares in Trading Halt Pending Capital Raising
Wellnex Life Limited (ASX:WNX) has initiated a trading halt pending a material capital raising announcement related to its UK LSE AIM listing.
Wellnex Life Limited (ASX:WNX) has initiated a trading halt pending a material capital raising announcement related to its UK LSE AIM listing.
Vitura Health Limited (ASX:VIT) acquires Candor Medical, enhancing its specialty healthcare services and boosting EBITDA.
EMVision Medical Devices (ASX:EMV) receives US IRB approval for pivotal trial of the emuâ„¢ brain scanner, maintaining progress towards March 2025 activation.
Clarity Pharmaceuticals (ASX:CU6) enhances its breast cancer pipeline with new radiopharmaceutical and secures critical supply agreement.
Ramsay Health Care (ASX:RHC) announces two non-recurring items impacting its 1H FY25 financial results, including UK segment impairment and tax provision release.
Alterity Therapeutics (ASX:ATH) secures A$40 million to advance ATH434 development for Parkinsonian disorders, supported by institutional investors.
Careteq Limited (ASX:CTQ) forms a strategic partnership with MedicAlert Foundation Australia to enhance medication safety for Australians.
Wellnex Life Limited (ASX:WNX) launches a non-renounceable entitlement offer to raise $22.1 million for strategic growth and debt redemption.
BTC Health (ASX:BTC) extends partnership with Arna Pharma, securing indefinite license and royalty agreements in key markets.
Micro-X Ltd (ASX:MX1) successfully raises $3.3M through capital placement, focusing on medical imaging and strategic partnerships.